MACD on monthly crossed down, a pull back to the MA's would present a good opportunity to add Should see support around the $2 mark
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025